You are viewing an incomplete version of our website. Please click to reload the website as full version.

SARS Envelope (C-Term) Peptide

Details for Product No. ABIN1382277, Supplier: Log in to see
Protein Name
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-SARS Coronavirus (SARS-CoV) (C-Term) antibody (ABIN1030639)
Characteristics 11 amino acids near the carboxy terminus of SARS E protein.
Application Notes SARS envelope peptide is used for blocking the activity of the SARS envelope.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Yonezawa, Tokunaga, Oshiro, Yoshino: "Raptor, a binding partner of target of rapamycin." in: Biochemical and biophysical research communications, Vol. 313, Issue 2, pp. 437-41, 2003

Marra, Jones, Astell, Holt, Brooks-Wilson, Butterfield, Khattra, Asano, Barber, Chan, Cloutier, Coughlin, Freeman, Girn, Griffith, Leach, Mayo, McDonald, Montgomery, Pandoh, Petrescu, Robertson et al.: "The Genome sequence of the SARS-associated coronavirus. ..." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1399-404, 2003

Hara, Yonezawa, Weng, Kozlowski, Belham, Avruch: "Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism." in: The Journal of biological chemistry, Vol. 273, Issue 23, pp. 14484-94, 1998